qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...

Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...

England has rolled out a new liquid biopsy test intended to fast-track lung cancer patients to receive targeted therapy.

Being diagnosed with cancer is one of the scariest things imaginable. But a cancer diagnosis doesn't have to be a death ...

A recently-approved treatment could take a BiTE out of small cell lung cancer by using a person's own body to fight back.

A new targeted cancer drug, DB-1310, is showing early signs of effectiveness in patients with advanced solid tumors that have ...

As a lung cancer advocate from Maine whose family has been impacted by this terrible disease, I am deeply concerned about the ...

Radiation therapy can treat lung cancer at all stages, easing symptoms, improving precision and minimizing side effects with ...

NHS England has announced the roll-out of a new liquid biopsy blood test to help lung cancer patients receive targeted ...

OncoHost, a technology company transforming the approach to precision oncology through proteomics and AI, today announced the publication of a new study in the Journal for ImmunoTherapy of Cancer ...

Announcing the rollout on the eve of the world’s largest cancer conference, which will take place in Chicago from Friday, NHS ...

Younger patients with lung cancer are more likely to have mutations that allow for targeted therapies, which can lead to more ...